Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge

Background Warfarin therapy in pediatric patients can be difficult to manage with bleeding as a primary adverse event. Therapy initiation can be difficult as doses to achieve therapeutic outcomes are being determined. Evaluation of readmission for bleeding in pediatric patients discharged on warfarin therapy may be useful to prevent adverse events. Methods The Pediatric Health Information System (PHIS) was queried to identify all patients